Equities

Clever Leaves Holdings Inc

CLVR:NAQ

Clever Leaves Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.70
  • Today's Change-0.03 / -1.73%
  • Shares traded64.17k
  • 1 Year change-78.37%
  • Beta2.8489
Data delayed at least 15 minutes, as of May 03 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

  • Revenue in USD (TTM)17.42m
  • Net income in USD-19.80m
  • Incorporated2020
  • Employees296.00
  • Location
    Clever Leaves Holdings IncBodega 19-B Parque Industrial Tibitoc PhTocancipa - CundinamarcaBOCA RATON 33487ColombiaCOL
  • Phone+1 6 468804382
  • Websitehttps://cleverleaves.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Twinlab Consolidated Holdings Inc13.62m-9.66m2.79m17.00------0.2045-0.0373-0.05290.0526-0.53660.91061.344.41801,000.00-64.61-60.53----36.8121.36-70.96-37.720.0157-0.0516-----20.87-28.58-20.28------
Panacea Life Sciences Holdings Inc2.38m-8.02m2.80m40.00------1.17-0.4882-0.48820.145-0.46990.12731.5310.1559,624.00-42.78-69.04-543.23-225.03-171.48-181.62-336.08-505.410.0331-2.093.29--46.59--12.33------
Novelstem International Corp12.00k-4.19m2.81m15.00------234.41-0.0893-0.08930.0003-0.04160.0053--2.00---171.11---188.15-------32,373.50-----9.822.20--0.00---446.84------
Avenue Therapeutics Inc0.00-10.38m2.82m3.00--1.03-----133.23-133.230.004.640.00----0.00-241.24-186.91-382.29-287.70-----------70.240.00-------192.15------
Eloxx Pharmaceuticals Inc0.00-20.48m2.83m18.00---------9.06-9.060.00-6.530.00----0.00-124.43-115.27---155.33-----------16.69--------45.95---22.56--
Cyclacel Pharmaceuticals Inc420.00k-22.76m2.93m12.00--3.49--6.97-26.72-26.720.49240.57320.0228--0.1106---122.40-57.58-212.95-69.81-----5,370.24-18,789.29---170.830.00----22.87-6.34---31.23--
Veritas Farms Inc730.65k-6.15m2.93m17.00--14.48--4.01-0.1319-0.13190.01360.00130.08770.80647.8042,979.41-69.02-72.11-123.21-93.59-220.0924.07-787.27-177.790.1392-5.560.95---63.42-0.942723.68---52.93--
4Cable TV International Inc758.68k-3.14m2.97m0.00------3.91-0.0624-0.06240.0157-0.04121.071.8425.22---441.73-82.30---308.1029.92---414.41-47.620.0064-0.5271-----0.0914---731.54------
Clever Leaves Holdings Inc17.42m-19.80m2.98m296.00--0.1213--0.1713-12.57-11.3811.1114.020.4181.6911.0358,841.21-47.51-23.20-58.14-26.5537.64---113.66-207.521.63-3.700.0479--6.14--47.63------
CanaQuest Medical Corp0.00-804.65k2.99m-----------0.0512-0.05120.00-0.03690.00-------1,084.38--------------------------57.42------
Marijuana Company Of America Inc1.50m-13.01m3.09m7.00------2.06-0.0071-0.00710.0003-0.00360.31375.617.64214,085.70-272.25-837.07----28.3739.75-867.96-3,809.920.031-0.6498----267.09159.6516.09------
Kiromic Biopharma Inc0.00-24.99m3.14m31.00---------29.21-29.210.00-3.810.00----0.00-171.18-161.49---213.01-----------15.691.87-------35.90--177.42--
Data as of May 03 2024. Currency figures normalised to Clever Leaves Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

6.90%Per cent of shares held by top holders
HolderShares% Held
AdvisorShares Investments LLCas of 31 Dec 202334.57k1.98%
Renaissance Technologies LLCas of 31 Dec 202334.34k1.97%
The Vanguard Group, Inc.as of 31 Dec 202315.14k0.87%
Geode Capital Management LLCas of 31 Dec 202310.64k0.61%
BlackRock Fund Advisorsas of 31 Dec 20239.94k0.57%
Amundi SGR SpAas of 31 Dec 20238.44k0.48%
Penserra Capital Management LLCas of 31 Dec 20235.09k0.29%
Tower Research Capital LLCas of 31 Dec 20232.18k0.13%
Morgan Stanley & Co. LLCas of 31 Dec 202344.000.00%
The Nemes Rush Group LLCas of 31 Dec 202332.000.00%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.